RxDoctor Payments Data

Gabrielle Bosworth, MD

Family Medicine · Portland, ORNPI 1437618691

Payments from drug & device makers

$440in general payments, 2019–2025

Across 21 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$105
  • Otsuka America Pharmaceutical, Inc.$68
  • Indivior Inc.$52
  • Axsome Therapeutics, Inc.$41
  • Pfizer$34
  • Novo Nordisk$25
  • plus $114 from 6 others

What the payments were for

  • Food & beverage$440100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$440 in reported general payments places this provider in the 75th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$4,091
Medicare patients
41
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$59,028
XareltoRivaroxaban57$41,354
JardianceEmpagliflozin33$26,705
TrulicityDulaglutide25$23,078
FarxigaDapagliflozin Propanediol34$21,869
EliquisApixaban30$19,499
Semglee (Yfgn) PenInsulin Glargine-Yfgn40$15,108
MounjaroTirzepatide15$15,026
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$7,066
Albuterol Sulfate HfaAlbuterol Sulfate106$3,746
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl29$2,912
Gabapentin154$2,693
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen89$2,512
Levothyroxine Sodium228$2,131
Celecoxib61$1,886

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$25$59,02860 claims
Lilly USA, LLCTrulicity, Mounjaro$14$38,10440 claims
AstraZenecaFarxiga$18$21,86934 claims
PfizerEliquis$34$19,49930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →